News Articles for "Early-stage Study"
Ahead of the Bell: Analyst rates Geron 'sell'
The drugmaker Geron Corp.'s development plan for the potential blood disorder treatment imetelstat is "flawed and sluggish," according to a Stifel analyst ...read more
Oncolytics details broader use for Reolysin
Shares of Oncolytics Biotech Inc. climbed Monday after the drug developer said its lead product Reolysin may have a broader use as a potential cancer treat...read more
Adult stem cell developer Neuralstem Inc. said Monday the Food and Drug Administration approved the company's plan for a small, early-stage study of its t...read more